# Pogejiuxin Decoction Combination of Conventional Western Medicine for the Treatment of Heart Failure With Preserved Ejection Fraction

> **NCT06629246** · NA · COMPLETED · sponsor: **Chongqing Traditional Chinese Medicine Hospital** · enrollment: 100 (actual)

## Conditions studied

- Heart Failure, Diastolic (HFpEF)

## Interventions

- **DRUG:** Conventional heart failure treatment
- **DRUG:** Pogejiuxin decoction combined with conventional heart failure treatment

## Key facts

- **NCT ID:** NCT06629246
- **Lead sponsor:** Chongqing Traditional Chinese Medicine Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2023-08-20
- **Final completion:** 2023-09-17
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-10-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06629246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06629246, "Pogejiuxin Decoction Combination of Conventional Western Medicine for the Treatment of Heart Failure With Preserved Ejection Fraction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06629246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*